VP

Vishva Pratik Kansara

Active Director Designated Partner DIN 11801209
DIN 11801209 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishva Pratik Kansara

Vishva Pratik Kansara is a Designated Partner at Cerata Biotech Llp (since 2026).

DIN 11801209
Primary Designation Designated Partner
First Appointment 02 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Jul 20262026Active

Board colleagues of Vishva Pratik Kansara

NameDINCompanyDesignation
Darshan Mohanbhai Khimani10015095Cerata Biotech LlpDesignated Partner
Hetal Darshan Khimani11801210Cerata Biotech LlpDesignated Partner
Pratik Dhirubhai Kansara10015096Cerata Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cerata Biotech Llp
Premium access

Shareholding and investment profile for Vishva Pratik Kansara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishva Pratik Kansara

Vishva Pratik Kansara currently holds 1 directorship: Cerata Biotech Llp (Designated Partner, since 02 Jul 2026).

Vishva Pratik Kansara was first appointed on 02 Jul 2026 as Designated Partner at Cerata Biotech Llp.

The current boards of Vishva Pratik Kansara's companies include Darshan Mohanbhai Khimani (Cerata Biotech Llp), Hetal Darshan Khimani (Cerata Biotech Llp), Pratik Dhirubhai Kansara (Cerata Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available